Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The role of speed versus working memory in predicting learning new information in multiple sclerosis.
Novel Inhibitors of Protein Arginine Deiminase with Potential Activity in Multiple Sclerosis Animal Model.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
How do autoimmune diseases cluster in families? A systematic review and meta-analysis.
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid and the diagnosis of multiple sclerosis.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
The treatment of neuromyelitis optica.
Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review.
IL1-β expression in multiple sclerosis.
Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls.
Oxidised LDL lipids, statins and a blood-brain barrier.
Core muscle characteristics during walking of patients with multiple sclerosis.
Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.
[Treatment of neuromyelitis optica].
[Alemtuzumab for relapsing-remitting multiple sclerosis : Results of two randomized controlled phase III studies.]
[Multiple sclerosis].
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
JCV epidemiology in MS (JEMS)-Epidemiology of anti-JCV antibody prevalence in multiple sclerosis patients-Portuguese data.
Management of fatigue in persons with multiple sclerosis.
Fingolimod prevents blood-brain barrier disruption induced by the sera from patients with multiple sclerosis.
The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methods.
Multiple sclerosis and pregnancy: therapeutic considerations.
ROCK in CNS: different roles of isoforms, and therapeutic target for neurodegenerative disorders.
Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS).

Pages